How is the landscape of Hodgkin lymphoma therapy changing?
Phase III ASPIRE study of carfilzomib, lenalidomide and dexamethasone in relapsed myeloma
Does the use of the checkpoint inhibitor nivolumab affect the outcomes of transplant?
Carmelo Carlo Stella
Results of Phase II trial to assess the efficacy and safety of idelalisib
ADCT-402 - a drug to watch